Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding

[1]  Virus-like Particle , 2020, Definitions.

[2]  Penmetcha K. R. Kumar.  Systematic screening of viral entry inhibitors using surface plasmon resonance , 2017, Reviews in medical virology.

[3]  Chao Zhang,et al.  Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor , 2017, Emerging Microbes &Infections.

[4]  M. Nogueira,et al.  The green tea molecule EGCG inhibits Zika virus entry. , 2016, Virology.

[5]  Xiang Cong,et al.  Epidemiological Research on Hand, Foot, and Mouth Disease in Mainland China , 2015, Viruses.

[6]  H. Chen,et al.  A dynamic model for the outbreaks of hand, foot, and mouth disease in Taiwan , 2015, Epidemiology and Infection.

[7]  C. Tai,et al.  Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds. , 2015, Journal of visualized experiments : JoVE.

[8]  D. Stuart,et al.  Structure Elucidation of Coxsackievirus A16 in Complex with GPP3 Informs a Systematic Review of Highly Potent Capsid Binders to Enteroviruses , 2015, PLoS pathogens.

[9]  D. Stuart,et al.  Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity , 2015, Journal of Virology.

[10]  Lie-Chwen Lin,et al.  Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry. , 2015, Antiviral research.

[11]  P. Chong,et al.  Review of enterovirus 71 vaccines. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  H. Hsieh,et al.  BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71. , 2014, Antiviral research.

[13]  Jianguo Wu,et al.  Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. , 2014, Biochemical and biophysical research communications.

[14]  Yuna Sun,et al.  Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71 , 2014, Protein & Cell.

[15]  D. Stuart,et al.  More powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules , 2014, Nature Structural &Molecular Biology.

[16]  Zhenglun Liang,et al.  Coxsackievirus A16 , 2014, Human vaccines & immunotherapeutics.

[17]  Chun-ching Lin,et al.  Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry , 2013, BMC Microbiology.

[18]  W. Huang,et al.  Atypical hand-foot-mouth disease in children: a hospital-based prospective cohort study , 2013, Virology Journal.

[19]  D. Stuart,et al.  Picornavirus uncoating intermediate captured in atomic detail , 2013, Nature Communications.

[20]  Z. Ku,et al.  Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. , 2013, Vaccine.

[21]  Qingwei Liu,et al.  Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16. , 2013, Vaccine.

[22]  Jen-Ren Wang,et al.  Immunological and Biochemical Characterization of Coxsackie Virus A16 Viral Particles , 2012, PloS one.

[23]  I. Sam,et al.  Enterovirus 71 Uses Cell Surface Heparan Sulfate Glycosaminoglycan as an Attachment Receptor , 2012, Journal of Virology.

[24]  Z. Ku,et al.  A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. , 2012, Vaccine.

[25]  K. Fujii,et al.  Human SCARB2-Dependent Infection by Coxsackievirus A7, A14, and A16 and Enterovirus 71 , 2012, Journal of Virology.

[26]  Gwyndaf Evans,et al.  A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71 , 2012, Nature Structural &Molecular Biology.

[27]  F. Zhou,et al.  In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection , 2012, Archives of Virology.

[28]  C. Richardson,et al.  Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread , 2011, Journal of Virology.

[29]  C. Schalley.  Modern Mass Spectrometry , 2010 .

[30]  T. Solomon,et al.  Clinical features, diagnosis, and management of enterovirus 71 , 2010, The Lancet Neurology.

[31]  H. Lei,et al.  Enterovirus 71 Infection of Monocytes with Antibody-Dependent Enhancement , 2010, Clinical and Vaccine Immunology.

[32]  Takashi Yoshida,et al.  Structural Features and Biological Properties of Ellagitannins in Some Plant Families of the Order Myrtales , 2010, International journal of molecular sciences.

[33]  M. Shimojima,et al.  Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71 , 2009, Nature Medicine.

[34]  S. Koike,et al.  Scavenger receptor B2 is a cellular receptor for enterovirus 71 , 2009, Nature Medicine.

[35]  A. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[36]  I. Kuntz,et al.  DOCK 6: combining techniques to model RNA-small molecule complexes. , 2009, RNA.

[37]  K. Goh,et al.  Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. , 2009, Annals of the Academy of Medicine, Singapore.

[38]  T. Wakita,et al.  Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. , 2008, The Journal of general virology.

[39]  Rémi Thomas,et al.  Fatal Coxsackievirus A-16 Pneumonitis in Adult , 2007, Emerging infectious diseases.

[40]  Mei-Ling Li,et al.  The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases. , 2007, Current medicinal chemistry.

[41]  S. Sheu,et al.  Chemical identification of the sources of commercial Fructus Chebulae. , 2005, Phytochemical analysis : PCA.

[42]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[43]  S. Sheu,et al.  Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. , 2004, Journal of separation science.

[44]  Chin‐Yun Lee,et al.  Fatal coxsackievirus A16 infection. , 2004, The Pediatric infectious disease journal.

[45]  T. van Ree,et al.  Tannins: classification and definition. , 2001, Natural product reports.

[46]  F. Hsu,et al.  Tannins and Related Compounds from Combretaceae Plants , 2000 .

[47]  David S. Jones,et al.  The Journal of Pharmacy and Pharmacology in the New Millennium , 2000 .

[48]  H. Ning,et al.  Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. , 1999, The Pediatric infectious disease journal.

[49]  Ta-chen Lin,et al.  Tannins and related compounds. CII. Structures of terchebulin, an ellagitannin having a novel tetraphenylcarboxylic acid (terchebulic acid) moiety, and biogenetically related tannins from Terminalia chebula Retz. , 1990 .

[50]  H. Pourianfar,et al.  Initial evidence on differences among Enterovirus 71, Coxsackievirus A16 and Coxsackievirus B4 in binding to cell surface heparan sulphate , 2013, VirusDisease.

[51]  Journal of Traditional and Complementary Medicine , 2022 .

[52]  Small Molecule Complexes , 2022 .